CBAY

CymaBay Therapeutics Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

-34.99

p/bv

13.22

DIVIDEND YIELD

0.00%

CBAY price

CymaBay Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CBAY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CBAY

Valuation

P/E

-34.99

Sector 1.14

Industry -1.74

P/BV

13.22

Sector 1.86

Industry 1.35

P/Revenue (PSR)

124.36

Sector 1.56

Industry 2.25

EV/EBITDA

-107.81

Sector -48.05

Industry -42.10

EV/EBIT

-107.67

Sector -27.46

Industry -45.23

P/EBITDA

-41.12

Sector -32.50

Industry -22.84

P/EBIT

-40.82

Sector -43.68

Industry -27.02

P/Total Assets

8.89

Sector 0.88

Industry 0.82

P/Net Current Assets

14.79

Sector -27.11

Industry -72.49

P/Working Capital

10.53

Sector 2.78

Industry -2.12

EPS

-0.93

Sector -0.70

Industry -1.11

BVPS

2.46

Sector 4.34

Industry 2.55

Efficiency

Gross Margin

100.00%

Sector 49.36%

Industry 50.48%

EBITDA Margin

-61,283.33%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

-61,366.67%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

-100.00%

Sector -19.73%

Industry -25.75%

Net Profit Margins

-100.00%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.00

Sector 0.13

Industry 0.06

Profitability

ROE

-37.80%

Sector -24.32%

Industry -33.33%

ROA

-25.41%

Sector -24.41%

Industry -45.73%

ROIC

-544.54%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

10.96

Sector 1.90

Industry 2.51

Net Debt / EBITDA

-2.70

Sector -4.96

Industry -8.98

Net Debt / EBIT

-2.69

Sector -3.08

Industry -37.38

Net Debt / Equity

0.34

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.34

Sector -0.74

Industry -0.56

Equity/Assets

0.67

Sector 0.46

Industry 0.52

Liabilities/Assets

0.67

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

3.20%

Sector -

Industry -

Fundamentals CBAY

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CBAY CymaBay Therapeutics Inc.	$0.00	-	0.00%	-34.99	13.22	-37.80%	-100.00%
LLY Eli Lilly and Compay	$1,152.93	54.29%	0.59%	38.16	30.09	78.84%	33.53%
SNY Sanofi	$42.48	-7.32%	4.17%	3.97	0.73	18.43%	14.25%
GSK GlaxoSmithKline PLC	$50.22	29.16%	3.54%	15.39	4.35	28.24%	14.54%
CRMD CorMedix Inc.	$7.72	-31.07%	0.00%	3.22	1.31	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$23.62	-14.54%	0.00%	13.18	1.35	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.19	-17.43%	0.69%	27.59	2.49	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.81	-94.85%	0.00%	0.01	0.01	63.85%	0.00%
ISRG Intuitive Surgical Inc.	$393.33	-10.35%	0.00%	44.01	7.60	17.26%	28.62%
NVS Novartis AG	$140.37	16.41%	2.22%	20.89	6.35	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$651.45	36.43%	0.28%	34.71	4.60	13.25%	15.07%
ABT Abbott Laboratories	$102.61	-22.85%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.13	0.84%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.34	-55.70%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$86.42	-29.33%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$224.99	-16.77%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$511.65	-22.02%	0.00%	35.48	25.07	70.67%	25.03%
HCA HCA Healthcare Inc.	$427.71	7.02%	0.70%	12.06	-29.52	-244.72%	10.07%
COHR Coherent Inc.	$317.36	190.86%	0.00%	75.62	5.36	7.09%	11.19%
DHR Danaher Corporation	$211.81	10.60%	0.68%	37.21	2.83	7.61%	15.95%
SYK Stryker Corp.	$275.12	-26.01%	1.26%	28.38	4.41	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CBAY Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT CymaBay Therapeutics

CymaBay Therapeutics Inc.

Average Investor10 user rating

4.0 (2 people)

United States

38 years

Founded: 1988

2014

Time since IPO - 12 years

44

Employees

CymaBay Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.87 billion, with shareholders equity totaling $292.26 million.

The company employs approximately 44 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, CymaBay Therapeutics Inc. reported $31.08 million in revenue, generating net income of $-105.37 million.

Key financial metrics include a P/E ratio of -34.99, a price-to-book (P/B) ratio of 13.22, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CBAY.

Market cap

$3.87 billion

Net worth

$292.26 million

$292,260,000.00

Assets

$434.69 million

$434,690,000.00

Total Shares Outstanding

119.00 million

119,000,000

Average Daily Trading Volume

$4.43 million

$4,427,424.06

Sector

Health

Industry

Pharmaceutical Products

CBAY

CBAY revenue and profits

Financial Results CBAY

DRAG THE FRAME TO SEE MORE DATA

CBAY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.84 22,33% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.28 --3,05% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.11 104,94% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$386.22 55,41% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.48 --7,32% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,152.93 54,29% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$427.71 7,02% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$140.37 16,41% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35